Predictions
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.50
15.02.24
15.02.24
-
15.02.25
15.02.25
-3.09%
17.02.24
17.02.24
Risky Investment
Glatfelter Corp.
Start price
Target price
Perf. (%)
€2.24
07.02.24
07.02.24
€1.00
07.02.25
07.02.25
-10.69%
17.02.24
17.02.24
Good culture
No Innovation
Risky Investment
Below average Management
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.35
05.02.24
05.02.24
-
05.02.25
05.02.25
29.34%
06.02.24
06.02.24
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Coherus Bioscien.
Start price
Target price
Perf. (%)
€1.88
05.02.24
05.02.24
-
05.02.25
05.02.25
33.90%
17.02.24
17.02.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
SynBiotic SE
Start price
Target price
Perf. (%)
€7.30
05.02.24
05.02.24
-
05.02.25
05.02.25
21.37%
17.02.24
17.02.24
Probably not worthwhile Investment
Below average Marketposition
Significant cyclical dependencies
Little known brand
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.32
05.02.24
05.02.24
-
05.02.25
05.02.25
-43.81%
08.02.24
08.02.24
Good culture
Risky Investment
No uniques
Green Hydrogen Systems A/S
Start price
Target price
Perf. (%)
€0.64
05.02.24
05.02.24
€1.00
05.02.25
05.02.25
13.04%
19.02.24
19.02.24
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
MacroGenics Inc.
Start price
Target price
Perf. (%)
€14.40
04.02.24
04.02.24
€20.00
30.11.25
30.11.25
-77.89%
13.05.24
13.05.24
Could be very worthwhile Investment >20% year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€0.98
04.02.24
04.02.24
€1.50
31.10.25
31.10.25
14.29%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
2CRSI S.A.
Start price
Target price
Perf. (%)
€3.90
03.02.24
03.02.24
-
03.02.25
03.02.25
31.79%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Mind Medicine MindMed Inc.
Start price
Target price
Perf. (%)
€3.74
03.02.24
03.02.24
-
03.02.25
03.02.25
136.09%
01.04.24
01.04.24
Revenue growth >5% per year expected
Medium risks for its business
Future proof or reliable business model
Probably not worthwhile Investment
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€22.48
31.01.24
31.01.24
-
29.02.24
29.02.24
230.87%
01.03.24
01.03.24
Novavax Inc.
Start price
Target price
Perf. (%)
€3.75
29.01.24
29.01.24
-
29.01.25
29.01.25
-2.03%
03.02.24
03.02.24
Could be very worthwhile Investment >20% year
Palisade Bio Inc.
Start price
Target price
Perf. (%)
€0.99
29.01.24
29.01.24
€1.00
29.01.25
29.01.25
-49.90%
03.02.24
03.02.24
Good culture
Capable Management
Could be worthwhile Investment >10% per year
Few uniques
RumbleON Inc.
Start price
Target price
Perf. (%)
€6.70
26.01.24
26.01.24
-
26.02.24
26.02.24
1.49%
27.02.24
27.02.24
Small challenges to pay loans and raise capital
Liquidia Technologies Inc
Start price
Target price
Perf. (%)
€10.58
25.01.24
25.01.24
€9.80
31.07.25
31.07.25
27.03%
17.02.24
17.02.24
Could be very worthwhile Investment >20% year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
25.01.24
25.01.24
€110.00
31.03.26
31.03.26
-0.66%
02.02.24
02.02.24
Could be very worthwhile Investment >20% year